Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPERS: Colchicine for Post-Ablation Pericarditis
NCT04906720Phase 2Completed
- Sponsor
- St. Vincent Cardiovascular Research Institute
- Start
- May 2021
- Primary completion
- Jan 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in pericarditis comparing Colchicine with Standard of Care (2 arms). Primary endpoint: Proportion of patients with Pericarditis at 30 days. Started May 2021; status: completed.
02
Drugs
colchicine
03
Conditions
pericarditis
Beyond the preview
Go deeper on NCT04906720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906720.